Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (Nature Cancer, (2022), 3, 2, (251-261), 10.1038/s43018-022-00332-x)

Cancer Core Europe consortium

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology (Nature Cancer, (2022), 3, 2, (251-261), 10.1038/s43018-022-00332-x)'. Together they form a unique fingerprint.

Medicine & Life Sciences